These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 17804206)

  • 1. Phencyclidine-induced cognitive deficits in mice are improved by subsequent subchronic administration of the glycine transporter-1 inhibitor NFPS and D-serine.
    Hashimoto K; Fujita Y; Ishima T; Chaki S; Iyo M
    Eur Neuropsychopharmacol; 2008 Jun; 18(6):414-21. PubMed ID: 17804206
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phencyclidine-induced cognitive deficits in mice are improved by subsequent subchronic administration of the antipsychotic drug perospirone: role of serotonin 5-HT1A receptors.
    Hagiwara H; Fujita Y; Ishima T; Kunitachi S; Shirayama Y; Iyo M; Hashimoto K
    Eur Neuropsychopharmacol; 2008 Jun; 18(6):448-54. PubMed ID: 18164909
    [TBL] [Abstract][Full Text] [Related]  

  • 3. D-Serine and a glycine transporter inhibitor improve MK-801-induced cognitive deficits in a novel object recognition test in rats.
    Karasawa J; Hashimoto K; Chaki S
    Behav Brain Res; 2008 Jan; 186(1):78-83. PubMed ID: 17854919
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of quetiapine on phencyclidine-induced cognitive deficits in mice: a possible role of alpha1-adrenoceptors.
    Tanibuchi Y; Fujita Y; Kohno M; Ishima T; Takatsu Y; Iyo M; Hashimoto K
    Eur Neuropsychopharmacol; 2009 Dec; 19(12):861-7. PubMed ID: 19656663
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phencyclidine-induced cognitive deficits in mice are ameliorated by subsequent subchronic administration of donepezil: role of sigma-1 receptors.
    Kunitachi S; Fujita Y; Ishima T; Kohno M; Horio M; Tanibuchi Y; Shirayama Y; Iyo M; Hashimoto K
    Brain Res; 2009 Jul; 1279():189-96. PubMed ID: 19433073
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phencyclidine-induced cognitive deficits in mice are improved by subsequent subchronic administration of the antibiotic drug minocycline.
    Fujita Y; Ishima T; Kunitachi S; Hagiwara H; Zhang L; Iyo M; Hashimoto K
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Feb; 32(2):336-9. PubMed ID: 17884273
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rescue of hippocampal LTP and learning deficits in a rat model of psychosis by inhibition of glycine transporter-1 (GlyT1).
    Manahan-Vaughan D; Wildförster V; Thomsen C
    Eur J Neurosci; 2008 Oct; 28(7):1342-50. PubMed ID: 18973561
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Animal model of schizophrenia: dysfunction of NMDA receptor-signaling in mice following withdrawal from repeated administration of phencyclidine.
    Nabeshima T; Mouri A; Murai R; Noda Y
    Ann N Y Acad Sci; 2006 Nov; 1086():160-8. PubMed ID: 17185514
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phencyclidine-induced cognitive deficits in mice are improved by subsequent subchronic administration of the novel selective alpha7 nicotinic receptor agonist SSR180711.
    Hashimoto K; Ishima T; Fujita Y; Matsuo M; Kobashi T; Takahagi M; Tsukada H; Iyo M
    Biol Psychiatry; 2008 Jan; 63(1):92-7. PubMed ID: 17601496
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transmembrane domains 1 and 3 of the glycine transporter GLYT1 contain structural determinants of N[3-(4'-fluorophenyl)-3-(4'-phenylphenoxy)-propyl]sarcosine specificity.
    Núñez E; Martínez-Maza R; Geerlings A; Aragón C; López-Corcuera B
    Neuropharmacology; 2005 Nov; 49(6):922-34. PubMed ID: 16143353
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phencyclidine-induced cognitive deficits in mice are improved by subsequent subchronic administration of tropisetron: role of alpha7 nicotinic receptors.
    Hashimoto K; Fujita Y; Ishima T; Hagiwara H; Iyo M
    Eur J Pharmacol; 2006 Dec; 553(1-3):191-5. PubMed ID: 17094961
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reversal of phencyclidine-induced dopaminergic dysregulation by N-methyl-D-aspartate receptor/glycine-site agonists.
    Javitt DC; Balla A; Burch S; Suckow R; Xie S; Sershen H
    Neuropsychopharmacology; 2004 Feb; 29(2):300-7. PubMed ID: 14560321
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phencyclidine-induced cognitive deficits in mice are improved by subsequent subchronic administration of clozapine, but not haloperidol.
    Hashimoto K; Fujita Y; Shimizu E; Iyo M
    Eur J Pharmacol; 2005 Sep; 519(1-2):114-7. PubMed ID: 16099452
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of the glycine transporter GlyT-1 potentiates the effect of risperidone, but not clozapine, on glutamatergic transmission in the rat medial prefrontal cortex.
    Konradsson A; Marcus MM; Hertel P; Svensson TH; Jardemark KE
    Synapse; 2006 Aug; 60(2):102-8. PubMed ID: 16715496
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurochemical and behavioral profiling of the selective GlyT1 inhibitors ALX5407 and LY2365109 indicate a preferential action in caudal vs. cortical brain areas.
    Perry KW; Falcone JF; Fell MJ; Ryder JW; Yu H; Love PL; Katner J; Gordon KD; Wade MR; Man T; Nomikos GG; Phebus LA; Cauvin AJ; Johnson KW; Jones CK; Hoffmann BJ; Sandusky GE; Walter MW; Porter WJ; Yang L; Merchant KM; Shannon HE; Svensson KA
    Neuropharmacology; 2008 Oct; 55(5):743-54. PubMed ID: 18602930
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glycine transporters type 1 inhibitor promotes brain preconditioning against NMDA-induced excitotoxicity.
    Pinto MC; Lima IV; da Costa FL; Rosa DV; Mendes-Goulart VA; Resende RR; Romano-Silva MA; de Oliveira AC; Gomez MV; Gomez RS
    Neuropharmacology; 2015 Feb; 89():274-81. PubMed ID: 25312280
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic effects of metabotropic glutamate receptor 5 positive allosteric modulator CDPPB on phencyclidine-induced cognitive deficits in mice.
    Horio M; Fujita Y; Hashimoto K
    Fundam Clin Pharmacol; 2013 Oct; 27(5):483-8. PubMed ID: 22594375
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel glycine transporter-1 (GlyT1) inhibitor, ASP2535 (4-[3-isopropyl-5-(6-phenyl-3-pyridyl)-4H-1,2,4-triazol-4-yl]-2,1,3-benzoxadiazole), improves cognition in animal models of cognitive impairment in schizophrenia and Alzheimer's disease.
    Harada K; Nakato K; Yarimizu J; Yamazaki M; Morita M; Takahashi S; Aota M; Saita K; Doihara H; Sato Y; Yamaji T; Ni K; Matsuoka N
    Eur J Pharmacol; 2012 Jun; 685(1-3):59-69. PubMed ID: 22542656
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glycine transporter inhibitors as a potential therapeutic strategy for chronic pain with memory impairment.
    Tanabe M; Takasu K; Yamaguchi S; Kodama D; Ono H
    Anesthesiology; 2008 May; 108(5):929-37. PubMed ID: 18431130
    [TBL] [Abstract][Full Text] [Related]  

  • 20. D(1)-like receptor activation improves PCP-induced cognitive deficits in animal models: Implications for mechanisms of improved cognitive function in schizophrenia.
    McLean SL; Idris NF; Woolley ML; Neill JC
    Eur Neuropsychopharmacol; 2009 Jun; 19(6):440-50. PubMed ID: 19268547
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.